This means apixaban cut the clot risk by nearly half. It also improved the chances of keeping the vascular access working without further issues (32% failure rate versus 50% in the control group).

CHICAGO — Extended therapy with reduced-dose apixaban is just as effective as the high dose in preventing recurrent venous thromboembolism (VTE) in patients with active cancer who completed at ...

The aim of the API-CAT trial was to assess whether the lower dose of apixaban was comparable to the full dose in preventing VTE recurrence in patients with active cancer who had completed at least ...

In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and ...

A new animated series from Disney-owned Pixar, "Win or Lose," features a character who makes a Christian prayer. Original plans to have a transgender character in the same show were scrapped.

Pixar's upcoming film Elio represents a return to original storytelling for the studio after a string of sequels. Fans are concerned that the success of Elio will determine the future focus on ...

CHICAGO, IL—For patients with active cancer who’ve had venous thromboembolism (VTE), 12-month extended anticoagulation with reduced-dose apixaban is noninferior to the full dose at preventing ...

A sequel to the Pixar animated film "Coco" is officially on the way, Disney CEO Bob Iger announced Thursday during a shareholder meeting. "While the film is just in the initial stages, we know it ...

Oh, Pixar — at it again with a funky concept that goes all in on the emotions. In the case of Win or Lose, the studio’s first television series, it’s all about externalizing internal ...

“Coco” director Lee Unkrich is returning to direct with Adrian Molina. Mark Nielsen, a Pixar veteran known for “Toy Story 4” and “Inside Out 2,” will produce.

Pixar is developing a ‘Coco’ sequel. Disney CEO Bob Iger made the announcement to shareholders. Directors Lee Unkrich and Adrian Molina are back. It seems to be the way of things these days ...